Concepedia

Author

Jean Lang

Sanofi (France)

Also Known As

Guy, Bruno, J LANG, J Lang, J M Lang, J. Lang, J. M. LANG, J. M. Lang, J.H. Lang, J.M. Lang, JEAN LANG

134

Publications

7K

Citations

45

H-Index

82

Concepts

All Affiliations

Sanofi (France)Institut Mérieux (France)Mahidol UniversityMahidol Oxford Tropical Medicine Research UnitInserm
JL

About

Jean Lang is an author at Sanofi (France) specializing in medicine, immunology, and vaccination.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

35

52

3.4K

2

Public Health

7

7

333

3

Engineering

3

3

138

4

Education

2

2

89

5

Health Sciences

1

1

47

Jean Lang

×

78

Publications

5.7K

Citations

43

H-Index

YearCitations

Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial

Arunee Sabchareon, Derek Wallace, Chukiat Sirivichayakul,

The Lancet

2012

805

Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres

Y Mouton, S. Alfandari, M. Valette,

AIDS

1997

363

Safety and Efficacy of Chimeric Yellow Fever-Dengue Virus Tetravalent Vaccine Formulations in Nonhuman Primates

Farshad Guirakhoo, Z. Zhang, Gene Myers,

Journal of Virology

2004

252

Treatment of Severe Colchicine Overdose with Colchicine-Specific Fab Fragments

Frédéric J. Baud, A. Sabouraud, Éric Vicaut,

New England Journal of Medicine

1995

233

Live Attenuated Chimeric Yellow Fever Dengue Type 2 (ChimeriVax™-DEN2) Vaccine: Phase I Clinical Trial for Safety and Immunogenicity: Effect of Yellow Fever Pre-immunity in Induction of Cross Neutralizing Antibody Responses to All

Farshad Guirakhoo, Scott Kitchener, Dennis Morrison,

Human Vaccines

2006

191

Safety and immunogenicity of tetravalent live-attenuated dengue vaccines in Thai adult volunteers: role of serotype concentration, ratio, and multiple doses.

Arunee Sabchareon, Jean Lang, Pornthep Chanthavanich,

American Journal of Tropical Medicine and Hygiene

2002

183

A Novel Tetravalent Dengue Vaccine Is Well Tolerated and Immunogenic against All 4 Serotypes in<i>Flavivirus</i>‐Naive Adults

Dennis Morrison, Thomas J. Legg, Christopher W. Billings,

The Journal of Infectious Diseases

2010

161

Safety and immunogenicity of a three dose regimen of two tetravalent live-attenuated dengue vaccines in five- to twelve-year-old Thai children

Arunee Sabchareon, Jean Lang, Pornthep Chanthavanich,

The Pediatric Infectious Disease Journal

2004

145

Evaluation of Interferences between Dengue Vaccine Serotypes in a Monkey Model

Bruno Guy, Véronique Barban, Nathalie Mantel,

American Journal of Tropical Medicine and Hygiene

2009

138

Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects

Bruno Guy, Nolwenn Nougarede, Sarah Begue,

Vaccine

2008

132

Page 1